John Stewart Sharman - 24 Mar 2020 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC

Role
Chief Executive Officer
Signature
/s/ John Sharman
Issuer symbol
N/A
Transactions as of
24 Mar 2020
Net transactions value
$0
Form type
4
Filing time
14 Sep 2021, 20:25:47 UTC
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding UBI Common Stock 276,217 24 Mar 2020 By wife F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBI Stock Option (Right to Buy) Gift $0 -1,000,000 -42% $0.000000 1,364,666 24 Mar 2020 Common Stock 1,000,000 $0.2000 Direct F2, F3, F4
transaction UBI Stock Option (Right to Buy) Gift $0 +1,000,000 $0.000000 1,000,000 24 Mar 2020 Common Stock 1,000,000 $0.2000 By wife F1, F2, F3, F4
transaction UBI Performance Rights Award $0 +2,500,000 $0.000000 2,500,000 19 Aug 2021 Common Stock 2,500,000 Direct F5
transaction UBI Performance Rights Award $0 +1,250,000 $0.000000 1,250,000 19 Aug 2021 Common Stock 1,250,000 Direct F6
holding UBI Stock Option (Right to Buy) 2,364,667 24 Mar 2020 Common Stock 2,364,667 $0.2500 Direct F2, F4
holding UBI Stock Option (Right to Buy) 1,364,667 24 Mar 2020 Common Stock 1,364,667 $0.3000 Direct F2, F4
holding UBI Stock Option (Right to Buy) 1,000,000 24 Mar 2020 Common Stock 1,000,000 $0.3000 By superannuation fund F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the shares held by his wife, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.
F2 The price reported is stated in Australian dollars.
F3 This transaction involved a gift of securities by the reporting person to his wife, who shares reporting person's household.
F4 The options are fully vested and became exercisable after September 24, 2020.
F5 Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
F6 Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.